NANETSBeyond's analysis on NANETS2026-10-07 — Perspective Therapeutics advances its radiopharmaceutical pipeline with accepted neuroendocrine tumor data for major symposium presentationRecent news mentioning NANETS2026-10-07 — Perspective Therapeutics Announces Acceptance of [212Pb]VMT-α-NET Data for Presentation at the NANETS 2026 Multidisciplinary NET Medical SymposiumAppears alongsideNETBrowse the full archive →